Immunoprecise Antibodies Ltd (IPA) Gross Profit Margin starting from the third quarter 2025 to third quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Immunoprecise Antibodies Ltd   (NASDAQ: IPA)


Immunoprecise Antibodies Ltd 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



IPA Gross Profit Margin (Jan 31 2026)
Q3
(Oct 31 2025)
Q2
(Jul 31 2025)
Q1
(Apr 30 2025)
Q4
(Jan 31 2025)
Q3
Y / Y Revenue Change 56.2 %
Seq. Revenue Change 0.9 %
Revenue In Millions $3.00
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 2456
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2025 Gross Profit Margin



Observing third quarter 2025 results within Major Pharmaceutical Preparations industry 239 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
IPA's Gross Profit Margin third quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 240
Healthcare Sector # 533
Overall # 2456

Gross Profit Margin Statistics
High Average Low
55.95 % 52.56 % 49.16 %
(Apr 30 2023)   (Apr 30 2024)




Other Gross Profit Margin Profitability Ratios
IPA's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
IPA's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for IPA's Competitors
Gross Profit Margin Profit Margin for Immunoprecise Antibodies Ltd 's Suppliers
Gross Profit Margin Profit Margin for IPA's Customers

You may also want to know
IPA's Annual Growth Rates IPA's Profitability Ratios IPA's Asset Turnover Ratio IPA's Dividend Growth
IPA's Roe IPA's Valuation Ratios IPA's Financial Strength Ratios IPA's Gross Profit Growth
IPA's Roa IPA's Inventory Turnover Ratio IPA's Growth Rates IPA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jan 31 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJan 31 2026 MRQ Gross ProfitJan 31 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.